Consciousness-Altering Drugs

Consciousness-altering drugs work by changing the level of activity in the nervous system, shifting a person out of ordinary waking consciousness and into a drug-induced altered state. They fall into a few broad categories — depressants, stimulants, opioids, and hallucinogens — each acting through its own set of receptors and neurotransmitter systems, but all capable of feeding into the same underlying reward circuitry that drives addiction.

Key Takeaways

• Depressants (alcohol, barbiturates, benzodiazepines) increase GABA receptor activity, opening a chloride channel and causing membrane hyperpolarization and brain inhibition; benzodiazepines increase channel-opening frequency while barbiturates increase opening duration, giving barbiturates a narrower safety margin.

• Alcohol also raises dopamine (mild euphoria); high doses impair reasoning and motor skills and produce alcohol myopia; chronic abuse causes liver, pancreatic, gastrointestinal, and neurological damage, including Wernicke-Korsakoff syndrome (thiamine deficiency).

• Stimulants (amphetamines, cocaine, MDMA) increase synaptic dopamine, norepinephrine, and serotonin. Amphetamines both promote release and block reuptake; cocaine only blocks reuptake. MDMA combines amphetamine-like stimulant effects with hallucinogenic ones.

• Opiates (naturally occurring: morphine, codeine) and opioids (semisynthetic: oxycodone, hydrocodone, heroin) bind opioid receptors, reducing pain and producing euphoria; overdose causes fatal respiratory suppression. Methadone treats opioid use disorder with lower overdose risk.

• Hallucinogens (LSD, mushrooms) act through poorly understood, largely serotonergic mechanisms, distorting perception and enhancing sensory experience. Marijuana (active chemical THC) acts at cannabinoid, glycine, and opioid receptors and can produce stimulant-, depressant-, or hallucinogen-like effects.

• Drug addiction is driven by the mesolimbic pathway (nucleus accumbens, ventral tegmental area, medial forebrain bundle) — one of four dopaminergic pathways in the brain, alongside the nigrostriatal (motor), mesocortical (cognition/affect), and tuberoinfundibular (prolactin) pathways. This pathway is activated by all addictive substances, as well as by gambling and falling in love.

Depressants

Depressants reduce nervous system activity, producing a sensation of relaxation and reduced anxiety. Alcohol is the most common depressant.

Alcohol increases activity at the GABA receptor, opening a chloride channel that causes hyperpolarization of the neuronal membrane. This produces general brain inhibition and diminished arousal. Alcohol also depresses the brain centers that normally prevent inappropriate behavior — which can make a person's behavior look less inhibited than it actually is — and increases dopamine levels, producing a mildly euphoric effect. At high doses, brain activity becomes more broadly disrupted: logical reasoning and motor skills suffer, fatigue sets in, and a drinker may lose the ability to recognize the consequences of their actions, a short-sighted view of the world known as alcohol myopia. Long-term alcohol abuse can cause cirrhosis and liver failure, pancreatic damage, gastric or duodenal ulcers, gastrointestinal cancer, and brain disorders — including Wernicke-Korsakoff syndrome, a deficiency in thiamine (Vitamin B1) characterized by severe memory impairment along with changes in mental status and loss of motor skills.

Barbiturates (such as amobarbital and phenobarbital) were historically used as anxiety-reducing (anxiolytic) and sleep medications. They have largely been replaced by benzodiazepines (such as alprazolam, lorazepam, diazepam, and clonazepam), which are less susceptible to overdose. Both drug classes work by increasing GABA activity, inducing a sense of relaxation, and both are highly addictive medications that can result in overdose — especially when taken together with alcohol.

MCAT Callout — Barbiturates vs. benzodiazepines: both are positive allosteric modulators of the GABA-A receptor, but they act on the chloride channel differently. Benzodiazepines increase the frequency with which the channel opens; barbiturates increase the duration each opening lasts. This mechanistic distinction is why barbiturates carry a narrower safety margin and higher overdose risk than benzodiazepines, even though both raise GABA activity overall.

Stimulants

Stimulants cause an increase in nervous system arousal by increasing the frequency of action potentials.

Amphetamines increase arousal by increasing the release of dopamine, norepinephrine, and serotonin at the synapse, and by decreasing the reuptake of these neurotransmitters. This produces an increase in arousal, a decreased appetite, and a decreased need for sleep. Physiologically, amphetamines increase heart rate and blood pressure; psychologically, they can produce euphoria, hypervigilance, anxiety, delusions of grandeur, and paranoia. Prolonged use of high dosages may result in brain damage or stroke, and long-term users usually suffer withdrawal marked by depression, fatigue, and irritability.

Cocaine, purified from the leaves of the coca plant or created synthetically, works by decreasing the reuptake of dopamine, norepinephrine, and serotonin — a different mechanism from amphetamines, but one that produces a similar set of effects. Cocaine also has anesthetic and vasoconstrictive properties, which allow it to be used in surgeries in highly vascularized areas such as the nose and throat; those same properties can lead to heart attacks and strokes when the drug is used recreationally. Crack is a smokable form of cocaine that is highly addictive.

MCAT Callout — Amphetamines vs. cocaine: both raise synaptic dopamine, norepinephrine, and serotonin, but not the same way. Amphetamines actively promote the release of these neurotransmitters in addition to blocking reuptake. Cocaine only blocks reuptake — it doesn't trigger extra release. The MCAT likes to test this mechanistic difference even though the resulting psychological and physiological effects look similar.

Ecstasy (3,4-methylenedioxy-N-methylamphetamine, or MDMA) acts as a hallucinogen combined with an amphetamine, sharing much of the amphetamines' mechanism and effects. Physiologically, it produces increased heart rate and blood pressure, blurry vision, sweating, nausea, and hyperthermia. Psychologically, it produces euphoria, increased alertness, and an overwhelming sense of well-being and connectedness.

Opiates and Opioids

Opiates and opioids are derived from the poppy plant, opium. Opiates are the naturally occurring forms of opium — morphine and codeine are examples. Opioids are semisynthetic derivatives of opium — oxycodone, hydrocodone, and heroin are examples. Both classes of compounds bind to opioid receptors in the peripheral and central nervous systems, causing a decreased reaction to pain and a sense of euphoria. Overdose can cause respiratory suppression, in which the brain stops sending the signals needed to breathe.

Heroin was originally created as a substitute for morphine but quickly became one of the most widely abused drugs; once injected, it is rapidly metabolized to morphine in the body. Heroin was once the most widely abused opioid, but that has since shifted toward prescription opioids — oxycodone and hydrocodone. Opioid use disorder is treated with methadone, a long-acting opioid with a lower overdose risk.

Hallucinogens

Hallucinogens include lysergic acid diethylamide (LSD) and many types of mushrooms. Their exact mechanism is unknown, but the proposed mechanism involves a complex interaction between various neurotransmitters, especially serotonin. Hallucinogens cause distortion of reality and fantasy, enhancement of sensory experiences, and introspection; physiologically, they can increase heart rate and blood pressure, dilate the pupils, and increase body temperature.

Marijuana comes from the leaves of two plants, Cannabis sativa and Cannabis indica. Its active chemical is tetrahydrocannabinol (THC), which exerts its effects by acting at cannabinoid receptors, glycine receptors, and opioid receptors — inhibiting GABA activity and indirectly increasing dopamine activity. Physiologically, marijuana produces eye redness, dry mouth, fatigue, impairment of short-term memory, increased heart rate, increased appetite, and lowered blood pressure. Psychologically, its effects can fall into any of the stimulant, depressant, or hallucinogen categories, which is why marijuana doesn't sit cleanly in a single drug class the way most other substances on this list do.

Drug Addiction and the Reward Pathway

Drug addiction is rooted in the mesolimbic pathway, one of four dopaminergic pathways in the brain. It includes the nucleus accumbens (NAc), the ventral tegmental area (VTA), and the medial forebrain bundle (MFB) — the pathway connecting the NAc and VTA. This circuit is normally involved in motivation and emotional response, and its activation accounts for the positive reinforcement of substance use. The addiction pathway is activated by every substance that produces psychological dependence — and, notably, by non-drug rewards too: gambling and falling in love also activate this same pathway.

MCAT Callout — The four dopaminergic pathways: the brain has four major dopamine pathways, and only one of them drives reward. The nigrostriatal pathway (substantia nigra to striatum) governs motor planning. The mesolimbic pathway (VTA to nucleus accumbens) is the reward pathway involved in addiction. The mesocortical pathway (VTA to cortex) affects cognition and affect. The tuberoinfundibular pathway (hypothalamus to pituitary) regulates prolactin release. Don't assume every dopaminergic pathway is "the addiction pathway" — only the mesolimbic pathway carries that role.

Why Consciousness-Altering Drugs Matter for the MCAT

This subtopic shows up constantly in passage-based questions describing a drug's receptor mechanism or a patient's overdose or withdrawal presentation, since each drug class hinges on a specific, testable mechanism. Watch for:

• Mechanism-matching. GABA receptor/chloride channel (alcohol, barbiturates, benzodiazepines); monoamine release and reuptake (amphetamines) vs. reuptake alone (cocaine); opioid receptors (opiates/opioids); poorly characterized serotonergic mechanisms (hallucinogens); cannabinoid receptors (marijuana).

• Barbiturates vs. benzodiazepines. Same receptor, different action on the chloride channel — duration (barbiturates) vs. frequency (benzodiazepines) — which explains their different overdose risk.

• Amphetamines vs. cocaine. Release-promoting plus reuptake-inhibiting vs. reuptake-inhibiting only, despite similar downstream effects.

• Opiates vs. opioids. Naturally occurring vs. semisynthetic — not interchangeable terms — and the shared mechanism of respiratory suppression in overdose.

• The mesolimbic pathway specifically, not dopaminergic activity generally, as the substrate of addiction.

Common MCAT Mistakes

• Confusing barbiturates and benzodiazepines' mechanisms — both increase GABA-A receptor activity, but barbiturates increase the duration the chloride channel stays open (higher overdose risk), while benzodiazepines increase the frequency it opens.

• Treating amphetamines and cocaine as mechanistically identical because their effects look similar — amphetamines promote monoamine release and block reuptake, while cocaine only blocks reuptake.

• Using "opiates" and "opioids" interchangeably — opiates are naturally occurring (morphine, codeine), while opioids are semisynthetic (oxycodone, hydrocodone, heroin).

• Assuming any dopaminergic pathway activation signals addiction — only the mesolimbic pathway (nucleus accumbens, ventral tegmental area, medial forebrain bundle) drives reward and addiction; the nigrostriatal, mesocortical, and tuberoinfundibular pathways serve motor, cognitive, and hormonal roles instead.

MCAT-Style Concept Check

Question: A patient overdoses on a sedative and shows severe respiratory depression that responds poorly to supportive care. A friend mentions the patient had been taking the medication together with alcohol. Which of the following drug classes is most consistent with this presentation, and what receptor-level mechanism explains its heightened overdose risk compared to a related drug class?

• A) Benzodiazepines; increased frequency of GABA-A chloride channel opening

• B) Barbiturates; increased duration of GABA-A chloride channel opening

• C) Opioids; agonism at GABA-A receptors

• D) Amphetamines; increased dopamine release and blocked reuptake

Answer: B

Explanation: Barbiturates increase the duration the GABA-A receptor's chloride channel stays open, which produces deeper, more prolonged CNS depression than benzodiazepines and gives barbiturates a narrower safety margin — especially dangerous when combined with another depressant like alcohol. Benzodiazepines (A) increase channel-opening frequency instead, which carries a lower overdose risk. Opioids (C) act at opioid receptors, not GABA-A receptors. Amphetamines (D) are stimulants that increase monoamine release, the opposite mechanism of a sedative causing respiratory depression.

FAQ

What's the difference between barbiturates and benzodiazepines?

Both increase activity at the GABA-A receptor, but they act on its chloride channel differently: barbiturates increase how long the channel stays open, while benzodiazepines increase how often it opens. That mechanistic difference is why barbiturates carry a higher overdose risk and have largely been replaced by benzodiazepines in clinical use.

What's the mechanistic difference between amphetamines and cocaine?

Amphetamines increase the release of dopamine, norepinephrine, and serotonin into the synapse in addition to blocking their reuptake. Cocaine only blocks reuptake of these neurotransmitters — it doesn't trigger extra release. Despite the different mechanisms, the resulting psychological and physiological effects look similar.

What's the difference between opiates and opioids?

Opiates are the naturally occurring forms of opium, such as morphine and codeine. Opioids are semisynthetic derivatives of opium, such as oxycodone, hydrocodone, and heroin. Both classes bind opioid receptors and can cause fatal respiratory suppression in overdose.

Why is the mesolimbic pathway specifically linked to addiction?

The mesolimbic pathway — connecting the ventral tegmental area to the nucleus accumbens via the medial forebrain bundle — is the brain's reward circuit. It's activated by every substance that produces psychological dependence, as well as by non-drug rewards like gambling and falling in love, which is why it's considered the biological substrate of addiction specifically, unlike the brain's other three dopaminergic pathways (nigrostriatal, mesocortical, tuberoinfundibular), which govern motor control, cognition/affect, and prolactin regulation instead.